MRK ▼ -0.4% - Merck & Co., Inc.
$MRK - Merck Showcases First-Time Pivotal Phase 3 Results From Oncology Pipeline and Continued Innovative Potential of Existing Portfolio at ESMO 2026
13-OCT-2026 06:53 AM ET
Share this post
More filings for $MRK
MRK ▲ +2.8% - Merck & Co., Inc.Oct 29, 2026MRK ▼ -2.4% - Merck & Co., Inc.Oct 26, 2026MRK ▼ -1.9% - Merck & Co., Inc.Oct 23, 2026MRK ▼ -0.9% - Merck & Co., Inc.Oct 22, 2026MRK ▼ -0.9% - Merck & Co., Inc.Oct 22, 2026MRK ▼ -2.3% - Merck & Co., Inc.Oct 22, 2026
View full $MRK filing history →💬 Comments
Loading comments…
Leave a comment